HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
ARDX
Ardelyx Inc
Healthcare Biotechnology · California, USA · Reports in usd
Market Cap: $1.45B
Market Cap
$1.45B
Enterprise Val
$1.39B
P/E Ratio
-23.47
P/B Ratio
8.66
Trailing PEG (1Y)
0.16
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$166.9M
Gross Margin91.34%
Profit Margin91.34%
Return on Equity-40.63%
Return on Assets-13.21%
Current Ratio4.31
Debt/Equity1.25
LT Debt/Equity1.24
Revenue Per Share0.52

Income Statement

Dec 31, 2025
Revenue$125.2M
Cost of Revenue$10.8M
Gross Profit$114.4M
R&D$22.9M
SG&A$86.4M
Operating Expenses$109.3M
Operating Income$5.1M
Interest Expense$5.8M
Tax Expense$7.0K
Net Income-$407.0K
EPS (Basic)$-0.01
EPS (Diluted)$-0.01
EBIT$5.4M
EBITDA$6.6M
Consolidated Income-$407.0K
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$68.0M
Accounts Receivable$71.8M
Inventory$123.1M
Current Assets$382.3M
LT Investments$0.00
Property, Plant & Equipment$7.0M
Intangibles$0.00
Non-Current Assets$119.3M
Total Assets$501.6M
Accounts Payable$19.2M
Current Debt$1.5M
Current Liabilities$88.6M
LT Debt$206.5M
Non-Current Liabilities$246.1M
Total Liabilities$334.7M
Total Debt$208.0M
Retained Earnings-$946.9M
Shareholder Equity$166.9M
Shares Outstanding242,974,306

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$21.0M
Investing Cash Flow$3.8M
Financing Cash Flow$557.0K
CapEx-$361.0K
Free Cash Flow$20.6M
Depreciation & Amort.$1.3M
Stock-Based Comp$12.4M
Acquisitions / Disposals$0.00
Investment Activity$4.1M
Debt Issued/Repaid$0.00
Equity Issued/Repaid$557.0K
Dividends Paid$0.00
Net Change in Cash$25.3M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h